Market Research Logo

Global Celiac Disease Drugs Market 2017-2021

Global Celiac Disease Drugs Market 2017-2021

About Celiac Disease Drugs

Celiac disease is an autoimmune inflammatory disease of the small intestine, which is triggered by intake of gluten from wheat and other sources through our food. Presently, there is no specific drug approved for celiac disease, and the first line of treatment is completely dominated by a gluten-free diet. There are few anti-inflammatory and immunosuppressant drugs and nutritional supplements that are used as off-label therapy in celiac disease. All these off-label therapies are considered as second-line of treatment.

Technavio’s analysts forecast the global celiac disease drugs market to grow at a CAGR of 24.22% during the period 2017-2021. Covered in this report

The report covers the present scenario and the growth prospects of the global celiac disease drugs market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

· Americas

· APAC

· EMEA

Technavio's report, Global Celiac Disease Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors



    · F. Hoffmann-La Roche

    · Johnson & Johnson

    · Merck

    · Pfizer
Other prominent vendors


    · ADMA Biologics

    · Amgen

    · Anthera Pharmaceuticals

    · Bayer

    · Biogen

    · BioLineRx

    · Biotest

    · Bristol-Myers Squibb

    · Celgene

    · Celimmune

    · ImmunogenX

    · Immunomedics

    · ImmusanT

    · Innovate Biopharmaceuticals

    · Kedrion Biopharma

    · LFB Group

    · Novartis

    · Shire

    · Takeda Pharmaceutical
Market driver
  • Prevalence of disease
  • For a full, detailed list, view our report
Market challenge
  • Long-term sustainability
  • For a full, detailed list, view our report
Market trend
  • Inorganic growth strategies
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
  • An overview of celiac disease
    • Table Stage 1: Initiation process in celiac disease
    • Table Stage 2: Triggering phase in celiac disease
    • Table Diagnostic approach for celiac disease
  • Market landscape
    • Market overview
      • Table Global celiac disease drugs market snapshot
      • Table Global celiac disease drugs market 2016-2021 ($ millions)
      • Table Opportunity analysis in global celiac disease treatment market
    • Five forces analysis
      • Table Five forces analysis
  • Pipeline landscape
    • Table Pipeline analysis of key molecules for celiac disease
    • Table Key clinical trials: Celiac disease drugs 2016
  • Market segmentation by therapy type
    • Table Segmentation of global celiac disease drugs market by therapy type 2016
    • First line of treatment
      • Table Global celiac disease first line of treatment market 2016-2021 ($ millions)
    • Second line of treatment
      • Table Various drug classes used in second line of treatment of celiac disease
      • Table Global celiac disease second line of treatment market 2016-2021 ($ millions)
  • Geographical segmentation
    • Table Segmentation of global celiac disease drugs market by geography 2016 and 2021
    • Table Segmentation of global celiac disease drugs market revenue by geography 2016- 2021 ($ millions)
    • Celiac disease drugs market in Americas
      • Table Market scenario in Americas
      • Table Celiac disease drugs market in Americas 2016-2021 ($ millions)
    • Celiac disease drugs market in EMEA
      • Table Market scenario in EMEA
      • Table Celiac disease drugs market in EMEA 2016-2021 ($ millions)
    • Celiac disease drugs market in APAC
      • Table Market Scenario in APAC
      • Table Celiac disease drugs market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Widely consumed foods containing gluten
      • Table The consumption rate of beer in US 2011-2015
      • Table Government initiatives by various countries for celiac disease
    • Market challenges
      • Table Various symptoms associated with celiac disease
      • Table Factors affecting long-term sustainability of gluten-free diet
  • Market trends
    • Inorganic growth strategies
      • Table Inorganic growth strategies for global celiac disease drugs market
    • Robust pipeline
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global celiac disease drugs market 2016
      • Table Competitive factors of global celiac disease drugs market
      • Table Market penetration of various celiac disease drugs manufacturers worldwide 2016
      • Table Strategic success factors of companies in global celiac disease drugs market
  • Key vendor analysis
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche: Key highlights
      • Table F. Hoffmann-La Roche: Strength assessment
      • Table F. Hoffmann-La Roche: Strategy assessment
      • Table F. Hoffmann-La Roche: Opportunity assessment
    • Johnson & Johnson
      • Table Johnson & Johnson: Key highlights
      • Table Johnson & Johnson: Strength assessment
      • Table Johnson & Johnson: Strategy assessment
      • Table Johnson & Johnson: Opportunity assessment
    • Merck
      • Table Merck: Key highlights
      • Table Merck: Strength assessment
      • Table Merck Strategy assessment
      • Table Merck: Opportunity assessment
    • Pfizer
      • Table Pfizer: Key highlights
      • Table Pfizer: Strength assessment
      • Table Pfizer: Strategy assessment
      • Table Pfizer: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report